Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report published by Market IntelliX, the global market for Pyrazinamide Tablets should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Pyrazinamide Tablets market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Pyrazinamide Tablets market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, 0.5g/Tablet segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Pyrazinamide Tablets include Akorn Operating, Healthy Life Pharma, Wellona Pharma, Lupin, Akorn, Cadila Pharmaceuticals, Macleods Pharma, Morningside Healthcare and Datong Liqun Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Pyrazinamide Tablets, indicated to be effective against mycobacterium only, are used in combination with other antituberculosis agents such as streptomycin, isoniazid, rifampicin and ethambutol to treat tuberculosis.
This report aims to provide a comprehensive study of the global market for Pyrazinamide Tablets. Report Highlights:
(1) Global Pyrazinamide Tablets market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Pyrazinamide Tablets market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Pyrazinamide Tablets market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Pyrazinamide Tablets segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Pyrazinamide Tablets segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Pyrazinamide Tablets, capacity, production and trends.
(7) Pyrazinamide Tablets industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
0.5g/Tablet
0.25g/Tablet
Market segment by application, can be divided into
Hospital
Clinic
Drugstore
Market segment by players, this report covers
Akorn Operating
Healthy Life Pharma
Wellona Pharma
Lupin
Akorn
Cadila Pharmaceuticals
Macleods Pharma
Morningside Healthcare
Datong Liqun Pharmaceutical
Guangdong Taicheng Pharmaceutical
Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)
Changchun Maoshun Pharmaceutical
Jiangsu Sihuan Bioengineering Pharmaceutical
Chongqing Huapont Pharmaceutical
Suzhou Homesun Pharmaceutical
Chengdu Jinhua Pharmaceutical
1 Market Overview
1.1 Pyrazinamide Tablets Definition
1.2 Global Pyrazinamide Tablets Market Size and Forecast
1.2.1 By Revenue, Global Pyrazinamide Tablets Market Size, 2018-2029
1.2.2 By Sales Volume, Global Pyrazinamide Tablets Market Size, 2018-2029
1.2.3 Global Pyrazinamide Tablets Price Trend, 2018-2029
1.3 China Pyrazinamide Tablets Market Size and Forecast
1.3.1 By Revenue, China Pyrazinamide Tablets Market Size, 2018-2029
1.3.2 By Sales Volume, China Pyrazinamide Tablets Market Size, 2018-2029
1.3.3 China Pyrazinamide Tablets Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Pyrazinamide Tablets Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Pyrazinamide Tablets Share in Global Market, 2018-2029
1.4.3 Pyrazinamide Tablets Market Size: China VS Global, 2018-2029
1.5 Pyrazinamide Tablets Market Dynamics
1.5.1 Pyrazinamide Tablets Market Drivers
1.5.2 Pyrazinamide Tablets Market Restraints
1.5.3 Pyrazinamide Tablets Industry Trends
1.5.4 Pyrazinamide Tablets Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Pyrazinamide Tablets Revenue by Company, 2018-2023
2.2 Global Pyrazinamide Tablets Sales Volume by Company, 2018-2023
2.3 Global Pyrazinamide Tablets Price by Company, 2018-2023
2.4 Global Pyrazinamide Tablets Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Pyrazinamide Tablets Concentration Ratio
2.6 Global Pyrazinamide Tablets Mergers & Acquisitions, Expansion Plans
2.7 Global Pyrazinamide Tablets Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Pyrazinamide Tablets Revenue by Company, 2018-2023
3.2 China Pyrazinamide Tablets Sales Volume by Company, 2018-2023
3.3 China Pyrazinamide Tablets Pyrazinamide Tablets Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Pyrazinamide Tablets Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Pyrazinamide Tablets Domestic VS Export
3.6 China Market, Pyrazinamide Tablets Import & Export
3.6.1 China Market, Pyrazinamide Tablets Import & Export, 2018-2029
3.6.2 China Pyrazinamide Tablets Import & Export Trends
3.6.3 Main Sources of China Pyrazinamide Tablets Import
3.6.4 Export Destination of China Pyrazinamide Tablets
4 Pyrazinamide Tablets Production by Region
4.1 Global Pyrazinamide Tablets Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Pyrazinamide Tablets Manufacturers
4.3 Global Major Manufacturers, Pyrazinamide Tablets Capacity Expansion and Future Plans
4.4 Global Pyrazinamide Tablets Capacity by Region
4.5 Global Pyrazinamide Tablets Production by Region
4.5.1 Global Pyrazinamide Tablets Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Pyrazinamide Tablets Production by Region, 2018-2023
4.5.3 Global Pyrazinamide Tablets Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Pyrazinamide Tablets Industry Chain
5.2 Pyrazinamide Tablets Upstream Analysis
5.2.1 Pyrazinamide Tablets Core Raw Materials
5.2.2 Main Manufacturers of Pyrazinamide Tablets Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pyrazinamide Tablets Production Mode
5.6 Pyrazinamide Tablets Procurement Model
5.7 Pyrazinamide Tablets Industry Sales Model and Sales Channels
5.7.1 Pyrazinamide Tablets Sales Model
5.7.2 Pyrazinamide Tablets Typical Distributors
6 Sights by Type
6.1 Pyrazinamide Tablets Classification
6.1.1 0.5g/Tablet
6.1.2 0.25g/Tablet
6.2 By Type, Global Pyrazinamide Tablets Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Pyrazinamide Tablets Revenue, 2018-2029
6.4 By Type, Global Pyrazinamide Tablets Sales Volume, 2018-2029
6.5 By Type, Global Pyrazinamide Tablets Price, 2018-2029
7 Sights by Application
7.1 Pyrazinamide Tablets Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Drugstore
7.2 By Application, Global Pyrazinamide Tablets Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Pyrazinamide Tablets Revenue, 2018-2029
7.4 By Application, Global Pyrazinamide Tablets Sales Volume, 2018-2029
7.5 By Application, Global Pyrazinamide Tablets Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Pyrazinamide Tablets Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Pyrazinamide Tablets Revenue, 2018-2029
8.3 By Region, Global Pyrazinamide Tablets Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Pyrazinamide Tablets Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Pyrazinamide Tablets Market Size Market Share
8.5 Europe
8.5.1 Europe Pyrazinamide Tablets Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Pyrazinamide Tablets Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pyrazinamide Tablets Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Pyrazinamide Tablets Market Size Market Share
8.7 South America
8.7.1 South America Pyrazinamide Tablets Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Pyrazinamide Tablets Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pyrazinamide Tablets Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Pyrazinamide Tablets Revenue, 2018-2029
9.3 By Country, Global Pyrazinamide Tablets Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Pyrazinamide Tablets Market Size, 2018-2029
9.4.2 By Company, U.S. Pyrazinamide Tablets Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Pyrazinamide Tablets Market Size, 2018-2029
9.5.2 By Company, Europe Pyrazinamide Tablets Sales Volume Market Share, 2022
9.5.3 By Type, Europe Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Pyrazinamide Tablets Market Size, 2018-2029
9.6.2 By Company, China Pyrazinamide Tablets Sales Volume Market Share, 2022
9.6.3 By Type, China Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Pyrazinamide Tablets Market Size, 2018-2029
9.7.2 By Company, Japan Pyrazinamide Tablets Sales Volume Market Share, 2022
9.7.3 By Type, Japan Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Pyrazinamide Tablets Market Size, 2018-2029
9.8.2 By Company, South Korea Pyrazinamide Tablets Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Pyrazinamide Tablets Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Pyrazinamide Tablets Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Pyrazinamide Tablets Market Size, 2018-2029
9.10.2 By Company, India Pyrazinamide Tablets Sales Volume Market Share, 2022
9.10.3 By Type, India Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Pyrazinamide Tablets Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Pyrazinamide Tablets Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Pyrazinamide Tablets Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Akorn Operating
10.1.1 Akorn Operating Company Information, Head Office, Market Area and Industry Position
10.1.2 Akorn Operating Pyrazinamide Tablets Models, Specifications and Application
10.1.3 Akorn Operating Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Akorn Operating Company Profile and Main Business
10.1.5 Akorn Operating Recent Developments
10.2 Healthy Life Pharma
10.2.1 Healthy Life Pharma Company Information, Head Office, Market Area and Industry Position
10.2.2 Healthy Life Pharma Pyrazinamide Tablets Models, Specifications and Application
10.2.3 Healthy Life Pharma Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Healthy Life Pharma Company Profile and Main Business
10.2.5 Healthy Life Pharma Recent Developments
10.3 Wellona Pharma
10.3.1 Wellona Pharma Company Information, Head Office, Market Area and Industry Position
10.3.2 Wellona Pharma Pyrazinamide Tablets Models, Specifications and Application
10.3.3 Wellona Pharma Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Wellona Pharma Company Profile and Main Business
10.3.5 Wellona Pharma Recent Developments
10.4 Lupin
10.4.1 Lupin Company Information, Head Office, Market Area and Industry Position
10.4.2 Lupin Pyrazinamide Tablets Models, Specifications and Application
10.4.3 Lupin Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Lupin Company Profile and Main Business
10.4.5 Lupin Recent Developments
10.5 Akorn
10.5.1 Akorn Company Information, Head Office, Market Area and Industry Position
10.5.2 Akorn Pyrazinamide Tablets Models, Specifications and Application
10.5.3 Akorn Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Akorn Company Profile and Main Business
10.5.5 Akorn Recent Developments
10.6 Cadila Pharmaceuticals
10.6.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.6.2 Cadila Pharmaceuticals Pyrazinamide Tablets Models, Specifications and Application
10.6.3 Cadila Pharmaceuticals Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Cadila Pharmaceuticals Company Profile and Main Business
10.6.5 Cadila Pharmaceuticals Recent Developments
10.7 Macleods Pharma
10.7.1 Macleods Pharma Company Information, Head Office, Market Area and Industry Position
10.7.2 Macleods Pharma Pyrazinamide Tablets Models, Specifications and Application
10.7.3 Macleods Pharma Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Macleods Pharma Company Profile and Main Business
10.7.5 Macleods Pharma Recent Developments
10.8 Morningside Healthcare
10.8.1 Morningside Healthcare Company Information, Head Office, Market Area and Industry Position
10.8.2 Morningside Healthcare Pyrazinamide Tablets Models, Specifications and Application
10.8.3 Morningside Healthcare Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Morningside Healthcare Company Profile and Main Business
10.8.5 Morningside Healthcare Recent Developments
10.9 Datong Liqun Pharmaceutical
10.9.1 Datong Liqun Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.9.2 Datong Liqun Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
10.9.3 Datong Liqun Pharmaceutical Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Datong Liqun Pharmaceutical Company Profile and Main Business
10.9.5 Datong Liqun Pharmaceutical Recent Developments
10.10 Guangdong Taicheng Pharmaceutical
10.10.1 Guangdong Taicheng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.10.2 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
10.10.3 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Guangdong Taicheng Pharmaceutical Company Profile and Main Business
10.10.5 Guangdong Taicheng Pharmaceutical Recent Developments
10.11 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)
10.11.1 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Company Information, Head Office, Market Area and Industry Position
10.11.2 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Models, Specifications and Application
10.11.3 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Company Profile and Main Business
10.11.5 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Recent Developments
10.12 Changchun Maoshun Pharmaceutical
10.12.1 Changchun Maoshun Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.12.2 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
10.12.3 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Changchun Maoshun Pharmaceutical Company Profile and Main Business
10.12.5 Changchun Maoshun Pharmaceutical Recent Developments
10.13 Jiangsu Sihuan Bioengineering Pharmaceutical
10.13.1 Jiangsu Sihuan Bioengineering Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.13.2 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
10.13.3 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Jiangsu Sihuan Bioengineering Pharmaceutical Company Profile and Main Business
10.13.5 Jiangsu Sihuan Bioengineering Pharmaceutical Recent Developments
10.14 Chongqing Huapont Pharmaceutical
10.14.1 Chongqing Huapont Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.14.2 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
10.14.3 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Chongqing Huapont Pharmaceutical Company Profile and Main Business
10.14.5 Chongqing Huapont Pharmaceutical Recent Developments
10.15 Suzhou Homesun Pharmaceutical
10.15.1 Suzhou Homesun Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.15.2 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
10.15.3 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Suzhou Homesun Pharmaceutical Company Profile and Main Business
10.15.5 Suzhou Homesun Pharmaceutical Recent Developments
10.16 Chengdu Jinhua Pharmaceutical
10.16.1 Chengdu Jinhua Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.16.2 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
10.16.3 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Chengdu Jinhua Pharmaceutical Company Profile and Main Business
10.16.5 Chengdu Jinhua Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Pyrazinamide Tablets Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Pyrazinamide Tablets Market Restraints
Table 3. Pyrazinamide Tablets Market Trends
Table 4. Pyrazinamide Tablets Industry Policy
Table 5. Global Pyrazinamide Tablets Revenue by Company, 2018-2023, US$ million
Table 6. Global Pyrazinamide Tablets Revenue Market Share by Company, 2018-2023
Table 7. Global Pyrazinamide Tablets Sales Volume by Company, 2018-2023, (K Boxes)
Table 8. Global Pyrazinamide Tablets Sales Volume Market Share by Company, 2018-2023
Table 9. Global Pyrazinamide Tablets Price by Company, 2018-2023, (US$/Box)
Table 10. Global Pyrazinamide Tablets Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pyrazinamide Tablets Mergers & Acquisitions, Expansion Plans
Table 12. Global Pyrazinamide Tablets Manufacturers Product Type
Table 13. China Pyrazinamide Tablets Revenue by Company, 2018-2023, US$ million
Table 14. China Pyrazinamide Tablets Revenue Market Share by Company, 2018-2023
Table 15. China Pyrazinamide Tablets Sales Volume by Company, 2018-2023, (K Boxes)
Table 16. China Pyrazinamide Tablets Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Pyrazinamide Tablets Production, Sales, Import and Export, 2018-2029, (K Boxes)
Table 18. China Pyrazinamide Tablets Import & Export Trends
Table 19. Main Sources of China Pyrazinamide Tablets Import
Table 20. Export Destination of China Pyrazinamide Tablets
Table 21. Global Headquarters and Manufacturing Base of Pyrazinamide Tablets Manufacturers
Table 22. Global Major Manufacturers, Pyrazinamide Tablets Capacity Expansion and Future Plans
Table 23. Global Pyrazinamide Tablets Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Boxes)
Table 24. Global Pyrazinamide Tablets Production by Region, 2018-2023, (K Boxes)
Table 25. Global Pyrazinamide Tablets Production Forecast by Region, 2023-2029, (K Boxes)
Table 26. Global Key Players of Pyrazinamide Tablets Upstream (Raw Materials)
Table 27. Global Pyrazinamide Tablets Typical Customers
Table 28. Pyrazinamide Tablets Typical Distributors
Table 29. By Type, Global Pyrazinamide Tablets Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Pyrazinamide Tablets Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Pyrazinamide Tablets Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Pyrazinamide Tablets Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Table 34. By Country, Global Pyrazinamide Tablets Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Pyrazinamide Tablets Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Pyrazinamide Tablets Revenue Market Share, 2018-2029
Table 37. By Country, Global Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Table 38. By Country, Global Pyrazinamide Tablets Sales Volume Market Share, 2018-2029
Table 39. Akorn Operating Company Information, Head Office, Market Area and Industry Position
Table 40. Akorn Operating Pyrazinamide Tablets Models, Specifications and Application
Table 41. Akorn Operating Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 42. Akorn Operating Company Profile and Main Business
Table 43. Akorn Operating Recent Developments
Table 44. Healthy Life Pharma Company Information, Head Office, Market Area and Industry Position
Table 45. Healthy Life Pharma Pyrazinamide Tablets Models, Specifications and Application
Table 46. Healthy Life Pharma Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 47. Healthy Life Pharma Company Profile and Main Business
Table 48. Healthy Life Pharma Recent Developments
Table 49. Wellona Pharma Company Information, Head Office, Market Area and Industry Position
Table 50. Wellona Pharma Pyrazinamide Tablets Models, Specifications and Application
Table 51. Wellona Pharma Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 52. Wellona Pharma Company Profile and Main Business
Table 53. Wellona Pharma Recent Developments
Table 54. Lupin Company Information, Head Office, Market Area and Industry Position
Table 55. Lupin Pyrazinamide Tablets Models, Specifications and Application
Table 56. Lupin Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 57. Lupin Company Profile and Main Business
Table 58. Lupin Recent Developments
Table 59. Akorn Company Information, Head Office, Market Area and Industry Position
Table 60. Akorn Pyrazinamide Tablets Models, Specifications and Application
Table 61. Akorn Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 62. Akorn Company Profile and Main Business
Table 63. Akorn Recent Developments
Table 64. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 65. Cadila Pharmaceuticals Pyrazinamide Tablets Models, Specifications and Application
Table 66. Cadila Pharmaceuticals Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 67. Cadila Pharmaceuticals Company Profile and Main Business
Table 68. Cadila Pharmaceuticals Recent Developments
Table 69. Macleods Pharma Company Information, Head Office, Market Area and Industry Position
Table 70. Macleods Pharma Pyrazinamide Tablets Models, Specifications and Application
Table 71. Macleods Pharma Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 72. Macleods Pharma Company Profile and Main Business
Table 73. Macleods Pharma Recent Developments
Table 74. Morningside Healthcare Company Information, Head Office, Market Area and Industry Position
Table 75. Morningside Healthcare Pyrazinamide Tablets Models, Specifications and Application
Table 76. Morningside Healthcare Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 77. Morningside Healthcare Company Profile and Main Business
Table 78. Morningside Healthcare Recent Developments
Table 79. Datong Liqun Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 80. Datong Liqun Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
Table 81. Datong Liqun Pharmaceutical Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 82. Datong Liqun Pharmaceutical Company Profile and Main Business
Table 83. Datong Liqun Pharmaceutical Recent Developments
Table 84. Guangdong Taicheng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 85. Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
Table 86. Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 87. Guangdong Taicheng Pharmaceutical Company Profile and Main Business
Table 88. Guangdong Taicheng Pharmaceutical Recent Developments
Table 89. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Company Information, Head Office, Market Area and Industry Position
Table 90. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Models, Specifications and Application
Table 91. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 92. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Company Profile and Main Business
Table 93. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Recent Developments
Table 94. Changchun Maoshun Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 95. Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
Table 96. Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 97. Changchun Maoshun Pharmaceutical Company Profile and Main Business
Table 98. Changchun Maoshun Pharmaceutical Recent Developments
Table 99. Jiangsu Sihuan Bioengineering Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 100. Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
Table 101. Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 102. Jiangsu Sihuan Bioengineering Pharmaceutical Company Profile and Main Business
Table 103. Jiangsu Sihuan Bioengineering Pharmaceutical Recent Developments
Table 104. Chongqing Huapont Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 105. Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
Table 106. Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 107. Chongqing Huapont Pharmaceutical Company Profile and Main Business
Table 108. Chongqing Huapont Pharmaceutical Recent Developments
Table 109. Suzhou Homesun Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 110. Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
Table 111. Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 112. Suzhou Homesun Pharmaceutical Company Profile and Main Business
Table 113. Suzhou Homesun Pharmaceutical Recent Developments
Table 114. Chengdu Jinhua Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 115. Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Models, Specifications and Application
Table 116. Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Sales Volume (K Boxes), Revenue (US$ Million), Price (US$/Box) and Gross Margin, 2018-2023
Table 117. Chengdu Jinhua Pharmaceutical Company Profile and Main Business
Table 118. Chengdu Jinhua Pharmaceutical Recent Developments
List of Figure
Figure 1. Pyrazinamide Tablets Picture
Figure 2. By Revenue, Global Pyrazinamide Tablets Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Pyrazinamide Tablets Market Size and Forecast, 2018-2029, (K Boxes)
Figure 4. Global Pyrazinamide Tablets Price Trend, 2018-2029, (US$/Box)
Figure 5. By Revenue, China Pyrazinamide Tablets Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Pyrazinamide Tablets Market Size and Forecast, 2018-2029, (K Boxes)
Figure 7. China Pyrazinamide Tablets Price Trend, 2018-2029 (US$/Box)
Figure 8. By Revenue, China Pyrazinamide Tablets Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Pyrazinamide Tablets Share of Global Market, 2018-2029
Figure 10. Global Pyrazinamide Tablets Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Pyrazinamide Tablets Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Pyrazinamide Tablets Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Pyrazinamide Tablets Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Pyrazinamide Tablets Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Pyrazinamide Tablets Domestic VS Export, 2022
Figure 16. Global Pyrazinamide Tablets Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Pyrazinamide Tablets Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Pyrazinamide Tablets Production Market Share & Forecast by Region, 2018-2029
Figure 19. Pyrazinamide Tablets Industry Chain
Figure 20. Pyrazinamide Tablets Procurement Model
Figure 21. Pyrazinamide Tablets Sales Model
Figure 22. Pyrazinamide Tablets Sales Channels, Direct Sales and Distribution
Figure 23. 0.5g/Tablet
Figure 24. 0.25g/Tablet
Figure 25. By Type, Global Pyrazinamide Tablets Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global Pyrazinamide Tablets Revenue Market Share, 2018-2029
Figure 27. By Type, Global Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 28. By Type, Global Pyrazinamide Tablets Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global Pyrazinamide Tablets Price, 2018-2029, (US$/Box)
Figure 30. Hospital
Figure 31. Clinic
Figure 32. Drugstore
Figure 33. By Application, Global Pyrazinamide Tablets Revenue, 2018-2029, US$ Million
Figure 34. By Application, Global Pyrazinamide Tablets Revenue Market Share, 2018-2029
Figure 35. By Application, Global Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 36. By Application, Global Pyrazinamide Tablets Sales Volume Market Share, 2018-2029
Figure 37. By Application, Global Pyrazinamide Tablets Price, 2018-2029, (US$/Box)
Figure 38. By Region, Global Pyrazinamide Tablets Revenue Market Share, 2018-2029
Figure 39. By Region, Global Pyrazinamide Tablets Sales Volume Market Share, 2018-2029
Figure 40. North America Pyrazinamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, North America Pyrazinamide Tablets Revenue Market Share, 2022
Figure 42. Europe Pyrazinamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, Europe Pyrazinamide Tablets Revenue Market Share, 2022
Figure 44. Asia Pacific Pyrazinamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country/Region, Asia Pacific Pyrazinamide Tablets Revenue Market Share, 2022
Figure 46. South America Pyrazinamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, South America Pyrazinamide Tablets Revenue Market Share, 2022
Figure 48. Middle East & Africa Pyrazinamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. U.S. Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 50. By Company, U.S. Pyrazinamide Tablets Market Share, 2022
Figure 51. By Type, U.S. Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 53. Europe Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 54. By Company, Europe Pyrazinamide Tablets Market Share, 2022
Figure 55. By Type, Europe Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, Europe Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 57. China Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 58. By Company, China Pyrazinamide Tablets Market Share, 2022
Figure 59. By Type, China Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, China Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 61. Japan Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 62. By Company, Japan Pyrazinamide Tablets Market Share, 2022
Figure 63. By Type, Japan Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, Japan Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 65. South Korea Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 66. By Company, South Korea Pyrazinamide Tablets Market Share, 2022
Figure 67. By Type, South Korea Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, South Korea Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 69. Southeast Asia Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 70. By Company, Southeast Asia Pyrazinamide Tablets Market Share, 2022
Figure 71. By Type, Southeast Asia Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, Southeast Asia Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 73. India Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 74. By Company, India Pyrazinamide Tablets Market Share, 2022
Figure 75. By Type, India Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, India Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 77. Middle East & Asia Pyrazinamide Tablets Sales Volume, 2018-2029, (K Boxes)
Figure 78. By Company, Middle East & Asia Pyrazinamide Tablets Market Share, 2022
Figure 79. By Type, Middle East & Asia Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, Middle East & Asia Pyrazinamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 81. Research Methodology
Figure 82. Breakdown of Primary Interviews
Figure 83. Bottom-up Approaches
Figure 84. Top-down Approaches
Research Methodology:
Pyrazinamide Tablets Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|